Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-23-001113

Options or other derivatives

  • Director acquired 25,561 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nicaise Claude · Director

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-03-16 Grant or award : show line 1 in the form Option to Purchase American Depositary Shares +6,857 6,857 D
2023-03-16 Grant or award : show line 2 in the form Option to Purchase American Depositary Shares +6,820 6,820 D
2023-03-16 Grant or award : show line 3 in the form Option to Purchase American Depositary Shares +11,884 11,884 D
Loading xslF345X04/zk2329429.xml…